We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+6.56%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$117M
AUM Growth
-$1.79M
Cap. Flow
-$4.28M
Cap. Flow %
-3.67%
Top 10 Hldgs %
27.63%
Holding
145
New
7
Increased
23
Reduced
48
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 46.82%
2 Technology 15.31%
3 Industrials 11.48%
4 Miscellaneous 10.93%
5 Consumer Staples 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STJ
1
DELISTED
St Jude Medical
STJ
$5.64M 4.84%
86,755
-1,700
-2% -$109K
RMTI icon
2
Rockwell Medical
RMTI
$32.9M
$4.97M 4.27%
4,397
+7
+0.2% +$7.18K
NEO icon
3
NeoGenomics
NEO
$2.32B
$3.41M 2.92%
816,680
+1,700
+0.2% +$7.81K
CSII
4
DELISTED
Cardiovascular Systems, Inc.
CSII
$3.09M 2.65%
102,700
HILL
5
DELISTED
DOT HILL SYSTEMS CORP
HILL
$2.88M 2.47%
651,106
-9,200
-1% -$38.7K
SPDC
6
DELISTED
SPEED COMMERCE, INC COM STK
SPDC
$2.72M 2.33%
879,500
+172,000
+24% +$479K
UPI
7
DELISTED
UROPLASTY INC-NEW
UPI
$2.65M 2.27%
1,284,788
-13,700
-1% -$32.5K
SVU
8
DELISTED
SUPERVALU Inc.
SVU
$2.45M 2.1%
36,062
+286
+0.8% +$17.9K
ALT icon
9
Altimmune
ALT
$605M
$2.4M 2.06%
4,429
-477
-10% -$245K
AAPL icon
10
Apple
AAPL
$4.67T
$1.99M 1.71%
72,120
+2,260
+3% +$61.5K
PFE icon
11
Pfizer
PFE
$159B
$1.99M 1.71%
67,276
DLX icon
12
Deluxe
DLX
$1.08B
$1.95M 1.67%
31,242
PLUS icon
13
ePlus
PLUS
$2.28B
$1.89M 1.62%
100,000
-4,000
-4% -$66K
BAX icon
14
Baxter International
BAX
$13.5B
$1.74M 1.49%
43,674
+1,105
+3% +$43K
ATRC icon
15
AtriCure
ATRC
$2.47B
$1.68M 1.44%
84,250
-500
-0.6% -$8.58K
RIOT icon
16
Riot Platforms
RIOT
$7.13B
$1.63M 1.4%
115,136
-6,962
-6% -$83.6K
IONS icon
17
Ionis Pharmaceuticals
IONS
$10.1B
$1.56M 1.34%
25,300
-3,165
-11% -$156K
ASRT
18
DELISTED
Assertio
ASRT
$1.5M 1.29%
1,553
+911
+142% +$831K
TULP
19
Bloomia Holdings
TULP
$1.48M 1.27%
59,124
-1,786
-3% -$40.2K
HPQ icon
20
HP
HPQ
$27.5B
$1.47M 1.26%
80,410
LMAT icon
21
LeMaitre Vascular
LMAT
$1.84B
$1.45M 1.24%
188,949
-2,000
-1% -$14.3K
AXGN icon
22
Axogen
AXGN
$2.77B
$1.42M 1.22%
396,050
+27,300
+7% +$79.9K
LLY icon
23
Eli Lilly
LLY
$1.05T
$1.41M 1.21%
20,450
SQNM
24
DELISTED
SEQUENOM INC NEW
SQNM
$1.41M 1.21%
380,200
XTNT icon
25
Xtant Medical Holdings
XTNT
$53.9M
$1.39M 1.2%
38,304
-7,019
-15% -$292K

Similar funds

Perkins Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Perkins Capital Management held 145 positions worth $117M, down 1.5% from $118M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Perkins Capital Management withdrew a net $4.28M in Q4 2014, closing 16 positions and reducing 48 holdings. Its most notable exit was Glu Mobile Inc., an estimated $1.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

Against the trend, Perkins Capital Management opened a new position in Synchrony worth $1.17M.

  • Perkins Capital Management's largest Q4 2014 buy was Synchrony: 39,200 shares worth $1.17M.
  • Perkins Capital Management added most to Assertio in Q4 2014, an estimated $831K increase.
  • Perkins Capital Management's biggest Q4 2014 reduction was AI Financial Corp, cutting an estimated $980K.
  • Perkins Capital Management fully exited Glu Mobile Inc. in Q4 2014, selling an estimated $1.6M.
  • Perkins Capital Management's ten largest holdings make up 28% of its $117M portfolio in Q4 2014.
  • Perkins Capital Management opened 7 new positions and closed 16 in Q4 2014.
  • Perkins Capital Management's portfolio value fell 1.5% quarter-over-quarter to $117M.

Based on Perkins Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.